WTF? Bad idea. It strikes me as @ASBrS overreaching. I mean seriously: Are we going to offer an 85 year old woman with a well-differentiated hormone receptor(+) cancer and no family history genetic testing? Why? It makes no sense. What will it accomplish for the patient?https://twitter.com/ESchattner/status/1096400867358593025 …
-
-
What's the downside? Draw the prep creatinine, INR, Brca1/2. It's time to stop viewing these simple and cheap tests as privileged or special.
1 reply 0 retweets 4 likes -
Shouldnt we avoid paying for tests that likely wont influence treatment decison-making?
1 reply 0 retweets 0 likes -
Preoperative brca1/2 would profoundly influence treatment decisions... risk reducing mastectomy, more intensive screening, oophorectomy, e.g.
1 reply 0 retweets 1 like -
For an 85 yr old with ER+?
1 reply 0 retweets 1 like -
Maybe, depends. But her brca+ daughter yes.
1 reply 0 retweets 2 likes -
An 85 year old with HR(+) disease would be INCREDIBLY unlikely to be BRCA+. A BRCA carrier would likely have gotten her cancer decades earlier, and it likely would have been HR(-). A blanket recommendation to consider genetic testing for ALL breast cancer patients is unjustified.
3 replies 0 retweets 2 likes
I'm seriously tempted to write a typically "insolent" blog post for @ScienceBasedMed on this topic, but I fear that it could get me in trouble professionally.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.